(Q35003765)

5 August 2017

1 reference

title

Current update of hormonal and psychotropic drug treatment of premenstrual dysphoric disorder (English)

1 reference

5 August 2017

Ellen W Freeman

1

1 reference

5 August 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

Current Psychiatry Reports

5 August 2017

published in

1 reference

5 August 2017

volume

4

1 reference

5 August 2017

issue

6

1 reference

5 August 2017

page(s)

435-440

1 reference

https://scigraph.springernature.com/pub.10.1007/s11920-002-0071-0

5 August 2017

exact match

0 references

cites work

Premenstrual syndrome and premenstrual dysphoric disorder

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11920-002-0071-0

Is premenstrual dysphoric disorder a distinct clinical entity?

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11920-002-0071-0

Clomipramine administered during the luteal phase reduces the symptoms of premenstrual syndrome: a placebo-controlled trial.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11920-002-0071-0

Treatment for the premenstrual syndrome with agnus castus fruit extract: prospective, randomised, placebo controlled study

21 January 2018

1 reference

12 December 2020

Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review

1 reference

12 December 2020

The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: experience from the United States, United Kingdom, and France

1 reference

12 December 2020

Efficacy of depot leuprolide in premenstrual syndrome: effect of symptom severity and type in a controlled trial

1 reference

12 December 2020

Current management of premenstrual syndrome and premenstrual dysphoric disorder

1 reference

12 December 2020

Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group

1 reference

12 December 2020

Hormonal interventions with psychopharmacological potential: an overview.

1 reference

12 December 2020

Fluoxetine treatment of severe premenstrual syndrome

1 reference

12 December 2020

Citalopram in PMS patients with prior SSRI treatment failure: a preliminary study

1 reference

12 December 2020

Intermittent luteal phase sertraline treatment of dysphoric premenstrual syndrome

1 reference

12 December 2020

Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome

1 reference

12 December 2020

Efficacy of Vitex agnus castus L. extract Ze 440 in patients with pre-menstrual syndrome (PMS).

1 reference

12 December 2020

Social pathways to premenstrual symptoms.

1 reference

12 December 2020

The treatment of severe premenstrual syndrome with goserelin with and without 'add-back' estrogen therapy: a placebo-controlled study

1 reference

12 December 2020

Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial

1 reference

12 December 2020

Oral contraceptives and mood

1 reference

12 December 2020

Treatment of premenstrual dysphoric disorder with sertraline during the luteal phase: a randomized, double-blind, placebo-controlled crossover trial

1 reference

12 December 2020

Buspirone in clinical practice

1 reference

12 December 2020

Diagnosis and treatment of premenstrual dysphoria.

1 reference

12 December 2020

Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial

1 reference

12 December 2020

The epidemiology of perimenstrual psychological symptoms.

1 reference

12 December 2020

A pilot study of Hypericum perforatum for the treatment of premenstrual syndrome

1 reference

12 December 2020

Fluoxetine in the treatment of premenstrual syndrome

1 reference

12 December 2020

Compliance to antidepressant drug therapy for treatment of premenstrual syndrome

1 reference

12 December 2020

Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial.

1 reference

12 December 2020

Prevalence, incidence and stability of premenstrual dysphoric disorder in the community

1 reference

12 December 2020

The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome

1 reference

12 December 2020

Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder

1 reference

12 December 2020

Premenstrual dysphoric disorder: a guide for patients and families

1 reference

12 December 2020

Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.

1 reference

12 December 2020

Buserelin in premenstrual syndrome

1 reference

12 December 2020

Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries

1 reference

12 December 2020

Intermittent fluoxetine dosing in the treatment of women with premenstrual dysphoria

1 reference

12 December 2020

Estrogen-serotonin interactions: implications for affective regulation.

1 reference

12 December 2020

Intermittent, luteal phase nefazodone treatment of premenstrual dysphoric disorder

1 reference

12 December 2020

The efficacy of fluoxetine in improving physical symptoms associated with premenstrual dysphoric disorder

1 reference

12 December 2020

Specificity of panic response to CO(2) inhalation in panic disorder: a comparison with major depression and premenstrual dysphoric disorder

1 reference

12 December 2020

Induced anovulation as treatment of premenstrual tension syndrome. A double-blind cross-over study with GnRH-agonist versus placebo

1 reference

12 December 2020

Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.

1 reference

12 December 2020

Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome.

1 reference

12 December 2020

Treatment of premenstrual dysphoria with alprazolam and placebo

1 reference

12 December 2020

Nefazodone in the treatment of premenstrual syndrome: a preliminary study

1 reference

12 December 2020

Venlafaxine in the treatment of premenstrual dysphoric disorder

1 reference

12 December 2020

Successful Treatment of Severe Premenstrual Syndrome by Combined Use of Gonadotropin-Releasing Hormone Agonist and Estrogen/Progestin*

1 reference

12 December 2020

Fluoxetine in the treatment of premenstrual dysphoria

1 reference

12 December 2020

Toward the content validity of premenstrual dysphoric disorder: do anger and irritability more than depressed mood represent treatment-seekers' experiences?

1 reference

12 December 2020

Premenstrual syndromes: closing the 20th century chapters

1 reference

12 December 2020

Complementary/alternative therapies for premenstrual syndrome: a systematic review of randomized controlled trials

1 reference

12 December 2020

Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study.

1 reference

12 December 2020

Depot leuprolide acetate with estrogen and progestin add-back for long-term treatment of premenstrual syndrome.

1 reference

12 December 2020

Treatment of premenstrual syndrome with a phytopharmaceutical formulation containing Vitex agnus castus.

1 reference

12 December 2020

Luteal phase sertraline treatment for premenstrual dysphoric disorder. Results of a double-blind, placebo-controlled, crossover study

1 reference

12 December 2020

Concurrent use of oral contraceptives with antidepressants for premenstrual syndromes

1 reference

12 December 2020

Evaluation of a unique oral contraceptive in the treatment of premenstrual dysphoric disorder

1 reference

12 December 2020

Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: a comparison of buspirone, nefazodone and placebo

1 reference

12 December 2020

Citalopram in premenstrual dysphoria: is intermittent treatment during luteal phases more effective than continuous medication throughout the menstrual cycle?

1 reference

12 December 2020

The role of central serotonergic dysfunction in the aetiology of premenstrual dysphoric disorder: therapeutic implications

1 reference

12 December 2020

From the food and drug administration: new indication for fluoxetine

1 reference

12 December 2020

Buspirone in treatment of premenstrual syndrome

1 reference

12 December 2020

Efficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic review

1 reference

12 December 2020

Treatment of premenstrual syndrome with fluoxetine: a double-blind, placebo-controlled, crossover study

1 reference

12 December 2020

10.1007/S11920-002-0071-0

Identifiers

DOI

1 reference

5 August 2017

1 reference